Related Experiment Video

Updated: Aug 9, 2026

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency
07:08

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

Published on: February 2, 2024

What's new in pancreatic cancer treatment pipeline?

Daniel D Von Hoff1

  • 1Translational Genomics Research Institute (TGen), 45 North 5th Street, Suite 600, Phoenix, AZ 85004, USA. dvh@tgen.org

Best Practice & Research. Clinical Gastroenterology
|March 22, 2006
PubMed

Insights

New pancreatic cancer treatments are emerging, focusing on therapeutic monoclonal antibodies, vaccines, and novel agents like gene therapy and hypoxia-targeting drugs. Ongoing research suggests promising advancements for patients with this challenging disease.

Area of Science:

  • Oncology
  • Cancer Therapeutics
  • Drug Development

Background:

  • Pancreatic cancer remains a significant unmet medical need, necessitating novel therapeutic strategies.
  • Current treatment options are limited, highlighting the urgency for research and development.

Purpose of the Study:

  • To review the current landscape of investigational agents for pancreatic cancer.
  • To document advancements in therapeutic monoclonal antibodies, vaccines, cytotoxics, gene therapy, and hypoxia-targeted agents.

Main Methods:

  • Review of agents in the pipeline with preliminary antitumor activity.
  • Analysis of agents initiating or soon to initiate clinical trials.
  • Examination of novel approaches including gene therapy and radiation enhancement.

Main Results:

  • Several classes of agents show promise, including therapeutic monoclonal antibodies and vaccines.
  • New conventional cytotoxics are under investigation.
  • Emerging therapies target specific mechanisms like hypoxia and protein overexpression.

Conclusions:

  • Significant research activity is underway in pancreatic cancer therapeutics.
  • Multiple novel therapeutic approaches are expected to emerge from ongoing clinical investigations.
  • Advancements in drug development offer hope for improved patient outcomes.

More Related Videos

Multianimal Magnetic Resonance Imaging for Tumor Measurements in Pancreatic Cancer Mouse Models09:18

Multianimal Magnetic Resonance Imaging for Tumor Measurements in Pancreatic Cancer Mouse Models

Published on: February 3, 2026

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.